Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F65B3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,015
Award facts
- Contract value 100% obligated
- $52,015.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $52,015.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside award was issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a task order against AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities across multiple therapeutic domains to federal agencies including the Defense Health Agency and the U.S. Coast Guard. The company's extensive portfolio under its DLA IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices. This specific delivery order for Zepbound reflects the company's ongoing role in fulfilling federal medical supply needs for diabetes and weight management treatments within the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F65B3?
SPE2DR26F65B3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F65B3 worth?
The government has obligated $52,015 on SPE2DR26F65B3.
Is contract SPE2DR26F65B3 an order under another contract?
Yes. SPE2DR26F65B3 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65B3 competed?
The extent of competition for SPE2DR26F65B3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award